Abstract
A newly developed membrane oxygenator “KMO” (KURARAY Co., Ltd., Kurasiki, Japan) was clinically used for extracorporeal membrane oxygenation (ECMO) in infant. This oxygenator is excellent in size (11×6.5×5cm), with low priming volume (45ml). The membrane, in which micropores are blind at the blood-contacting surface, prevents serum leakage, arid has long-term stability in gas-exchange performance. So we conclude, this oxygenator is suitable for ECMO.